← Back to directory
B

Boehringer Ingelheim Venture Fund

🇬🇧 UK-active
Seed VC·Ingelheim, Germany·Partner: Martin Heidecker (Managing Director)

stages Seed, Series A; cheque €1M - €15M.

Cheque range (GBP)
£1.0M – £15M
Typical: €1M - €15M
Last cheque
5mo ago
quieter recently
Rounds (12mo)
2
none in last 90d
Tracked portfolio
1
since 2026

Recent investments

1 tracked rounds via funding databases
CompanyAmountWhen
Brainomix ↗
Develops AI-powered imaging tools for stroke and lung fibrosis
$6.8M5mo ago

Stages backed

Series C+1 · 100%

Sectors & focus

AI / MLB2B SaaSHealthtechBiotech / Life SciencesEdtechAIMachine LearningSaaSEnterpriseMedTechBiotech
Business models
SaaS, AI / ML, Deep tech

Other portfolio companies

1 from public sources
Brainomix Limited

Frequent co-investors

From tracked deal data
HostplusModi VenturesParkwalk AdvisorsTencent

Want a match-quality estimate?

Score your pitch and we'll tell you if Boehringer Ingelheim Venture Fund matches your stage, sector, and cheque — before you ever email them.

Score my pitch →
For the team at Boehringer Ingelheim Venture Fund

This profile isn't claimed yet.

Claim it to correct your mandate, fix anything that's wrong, and start receiving UK founders who actually fit what you back.

Claim this profile →